SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-177263
Filing Date
2004-10-25
Accepted
2004-10-25 16:48:58
Documents
14
Period of Report
2004-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 463260
2 CHANGE IN CONTROL dex101.htm EX-10.1 36974
3 EMPLOYMENT AGREEMENT dex102.htm EX-10.2 30422
4 CHANGE IN CONTROL dex103.htm EX-10.3 37270
5 EMPLOYMENT AGREEMENT dex104.htm EX-10.4 29895
6 CHANGE IN CONTROL dex105.htm EX-10.5 37105
7 EMPLOYMENT AGREEMENT dex106.htm EX-10.6 29971
8 CHANGE IN CONTROL dex107.htm EX-10.7 37044
9 EMPLOYMENT AGREEMENT dex108.htm EX-10.8 30189
10 CHANGE IN CONTROL dex109.htm EX-10.9 37002
11 EMPLOYMENT AGREEMENT dex1010.htm EX-10.10 30743
12 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex311.htm EX-31.1 9515
13 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex312.htm EX-31.2 9445
14 SECTION 1350 CERTIFICATION dex32.htm EX-32 4880
  Complete submission text file 0001193125-04-177263.txt   827060
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-Q | Act: 34 | File No.: 000-04829 | Film No.: 041094403
SIC: 2836 Biological Products, (No Diagnostic Substances)